ArticleACS catalysis2024
A Resorcin[4]arene-Based Phosphite-Phosphine Ligand for the Branched-Selective Hydroformylation of Alkyl Alkenes.
Article in ACS catalysis, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Exclusive Hydroformylation of Terminal Olefins: A Phosphorus-Free Ruthenium System for the Selective Functionalization of Complex Mixtures.Angewandte Chemie (International ed. in English) · 2026Article
- Recent Advances in the Synthesis and Applications of Nitrogen-Containing Macrocyclic Arenes.Molecules (Basel, Switzerland) · 2025Review
- A Very Readily Prepared Ligand for Rhodium Catalyzed Propene Hydroformylation.Chemistry (Weinheim an der Bergstrasse, Germany) · 2025Article
- Cis-Chelating Diphosphanes for Intracavity Nickel(II)-Catalyzed Ethylene Oligomerization.Chemistry (Weinheim an der Bergstrasse, Germany) · 2025Article
- Effect of the Positioning of Metal Centers on a Cavitand in the Ruthenium-CatalyzedMolecules (Basel, Switzerland) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Synthesis of a chelating phosphite-phosphine ligand from a tris(quinoxaline) extended resorcin[4]arene and its application in the rhodium-catalyzed hydroformylation of terminal alkyl alkenes are reported. Rhodium complexes are formed within the cavity of the macrocycle and branched-selective hydroformylation of 1-octene with a
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.